Most readers would already know that Cochlear's (ASX:COH) stock increased by 1.5% over the past month. Given that the market rewards strong financials in the long-term, we wonder if that is the case ...
Could The Market Be Wrong About Cochlear Limited (ASX:COH) Given Its Attractive Financial Prospects?
It is hard to get excited after looking at Cochlear's (ASX:COH) recent performance, when its stock has declined 7.6% over the past three months. However, a closer look at its sound financials might ...
Cochlear Limited, which creates implantable hearing devices, has taken a technological leap forward with a device that syncs up with various Apple products. The Nucleus 7 Sound Processor, which was ...
LONE TREE, Colo., March 3, 2025 /PRNewswire/ — In celebration of World Hearing Day, Cochlear, the global leader in implantable hearing solutions, is proud to announce that it has been named the number ...
Cochlear Ltd (CHEOY) recently announced a dividend of $0.66 per share, payable on 2024-04-30, with the ex-dividend date set for 2024-03-21. As investors look forward to this upcoming payment, the ...
Cochlear Limited (AU:COH) has released an update. Cochlear Limited recently reported changes in the interests of its director, Diggory William Howitt, involving the acquisition of 11,000 shares and ...
CENTENNIAL, Colo., June 17, 2019 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, today announced the U.S. Food and Drug Administration's (FDA) approval ...
Thank you for standing by, and welcome to the Cochlear Limited Half Year 2025 Results Analyst and Media Briefing. All participants are in listen-only mode. There will be presentation, followed by a ...
Cochlear (ASX:COH) has had a rough three months with its share price down 16%. But if you pay close attention, you might gather that its strong financials could mean that the stock could potentially ...
Cochlear Limited, a medical device company specializing in implantable hearing solutions, is launching two new bone conduction sound processor devices for patients with high levels of hearing loss.
MONTPELLIER, France & SYDNEY--(BUSINESS WIRE)--Regulatory News: Sensorion (Paris:ALSEN) (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology, which specializes in the development of novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results